Apollo Hospitals Enterprises Limited and five of its directors have finally closed a long-running foreign exchange regulatory case. The Enforcement Directorate (ED) terminated adjudication proceedings after the Reserve Bank of India (RBI) issued a compounding order under Section 15 of the Foreign Exchange Management Act (FEMA). The settlement involved a one-time payment of ₹17.76 crore by the company and ₹18 lakh each by five directors and officers—Preetha Reddy, Suneetha Reddy, S.K. Venkatraman, Akhileswaran Krishnan, and S.M. Krishnan.
This resolution brings an end to all further litigation related to these specific FEMA violations, providing the company with regulatory certainty after a period of investigation and uncertainty.
The compounding process is essentially a legal settlement mechanism under FEMA. It allows entities to voluntarily admit to violations, pay a monetary penalty, and regularize the contravention without undergoing lengthy litigation or prosecution. Here’s how it unfolded in Apollo’s case:
The ED initiated an investigation based on credible information and subsequently filed a complaint under Section 16 of FEMA before the Adjudicating Authority. Apollo Hospitals then approached the RBI seeking compounding of the alleged contraventions under Section 15 of FEMA. Following a reference from the RBI, the ED issued a no-objection certificate “in line with the true spirit of the Act,” after which the RBI passed the compounding order.
The ED has been actively promoting the compounding provision in select FEMA cases since last year, as part of the government’s “ease of doing business” initiative and as a measure to reduce prolonged litigation. This approach prioritizes voluntary compliance and rectification over punitive enforcement for technical violations.
The ED identified four major categories of FEMA violations that totaled more than ₹2,424 crore:
FDI in Prohibited Sector: Apollo Hospitals received foreign direct investment (FDI) in retail trading—a sector prohibited for FDI—and subsequently received FDI without the requisite government approval. The amount involved in this contravention was ₹859.87 crore.
FCCB Issuance: The company issued Foreign Currency Convertible Bonds (FCCBs) valued at ₹70.02 crore in alleged violation of FEMA regulations.
FII-PIS Route Breach: Apollo received foreign investment under the Foreign Institutional Investor-Portfolio Investment Scheme (FII-PIS) route that breached the 24% paid-up capital limit. The amount involved was ₹623.87 crore.
Sectoral Cap Violation: The company breached the overall sectoral cap of 51% prescribed for foreign shareholding in multi-brand retail trading. The amount involved in this contravention was ₹870.66 crore.
The settlement cost represents a manageable financial impact for Apollo Hospitals. The ₹17.76 crore payment is just 3.07% of the company’s cash and cash equivalents of ₹578.1 crore (FY25) and only 0.83% of its annual operating cash flow of ₹2,136.4 crore .
In terms of profitability, the settlement represents approximately 2.69% of the company’s quarterly net profit of ₹660.5 crore (FY26 Q4). On an annualized basis, assuming similar quarterly performance, the settlement would be roughly 0.67% of annual profit—minimal dilution to shareholder earnings .
The liability allocation reflects a clear principle: the corporate entity bears the primary responsibility. Apollo Hospitals paid ₹17.76 crore (95.2% of the total settlement), while the five directors and officers each paid ₹18 lakh (4.8% combined). This structure acknowledges that FEMA violations primarily constitute corporate regulatory breaches while still holding individuals accountable for governance and oversight failures.
The RBI’s decision to approve compounding instead of pursuing full adjudication was influenced by several factors. The ED has been promoting compounding provisions in select FEMA cases as part of the government’s “ease of doing business” initiative and to reduce litigation.
Compounding provides certainty and closure. It eliminates ongoing legal uncertainty and potential escalating costs. The voluntary nature of the process—where entities admit to contraventions and settle by paying a monetary penalty—aligns with the “true spirit of the Act,” as the ED noted in its no-objection statement.
Under FEMA, quantifiable contraventions can attract penalties up to three times the sum involved. In this case, that could have theoretically reached up to ₹7,272 crore. The actual settlement represents a 99.2% reduction from this maximum potential penalty exposure, making compounding a financially prudent resolution.
The closure of this case removes a significant regulatory overhang, positioning Apollo Hospitals to rebuild foreign investor relationships and access global capital markets more effectively. With the FDI-in-retail violation resolved, the company can now pursue legitimate foreign investment opportunities in permitted healthcare sectors without regulatory baggage.
The compounding of the ₹70.02 crore FCCB violation clears the path for future foreign currency convertible bond issuances, providing access to cost-effective foreign capital. Having addressed the shareholding limit breaches, the company can now structure foreign investments within prescribed regulatory limits.
However, this freedom comes with responsibility. Apollo Hospitals will need to implement comprehensive compliance upgrades to prevent recurrence. This includes automated sectoral cap monitoring systems, pre-issuance regulatory clearance for FCCBs, real-time foreign investment tracking, and enhanced board-level oversight of compliance matters.
The resolution of the FEMA case is likely to positively influence investor perception and valuation multiples. Investors typically value certainty over uncertainty. The complete termination of adjudication proceedings eliminates the discount associated with pending litigation.
Apollo Hospitals’ strong operational fundamentals support this positive outlook. FY26 consolidated revenue grew 16% year-over-year to ₹252,285 million, with EBITDA up 25% and PAT up 34%. Q4 FY26 was particularly strong, with revenue growing 18% YoY to ₹66,055 million, EBITDA up 31% to ₹10,109 million, and PAT up 36% to ₹5,292 million.
The combination of strong operational performance and regulatory clarity could support P/E multiple expansion from current levels, particularly as foreign investors regain confidence in the company’s compliance framework. The current P/E ratio of 60.54× and EV/EBITDA of 40.85× may see adjustments as the regulatory risk premium decreases .
The RBI’s compounding approval sends an important signal to the healthcare sector: voluntary compliance and rectification are valued over punitive enforcement for technical violations. The settlement ratio of 0.73% provides a benchmark for potential compliance resolution costs, while the individual director penalties demonstrate personal responsibility without excessive burden.
This precedent is likely to reduce the regulatory risk premium for the healthcare sector’s foreign capital transactions. Healthcare companies face unique challenges—multi-sector operations, complex foreign investment structures, and evolving regulatory landscapes. The Apollo case establishes that technical FEMA violations can be resolved through compounding, providing clarity on potential outcomes.
The settlement may drive structural changes across the sector. Companies can expect increased scrutiny of foreign investment compliance, but also clearer pathways for resolution. There’s likely to be significant investment in compliance infrastructure, enhanced board-level oversight, and greater use of technology for compliance monitoring and reporting.
Apollo Hospitals’ ₹17.76 crore FEMA settlement represents more than just a financial resolution—it’s a strategic reset. The company has emerged from a ₹2,424 crore regulatory cloud with a manageable one-time cost, a clean regulatory slate, and a roadmap for enhanced compliance.
For investors, the removal of regulatory uncertainty combined with strong operational fundamentals creates a more attractive investment proposition. For the healthcare sector, the settlement establishes an important precedent for resolving technical FEMA violations while emphasizing the critical importance of robust compliance frameworks.
The message is clear: proactive compliance and voluntary rectification are the preferred path forward. Companies that embrace this approach will likely find themselves better positioned to access foreign capital and navigate India’s evolving regulatory landscape.
